'Intermediate risk' diaporamas de présentation

General IM Board Review

1.26k views • 110 slides

1.17k views • 96 slides

NONCARDIAC SURGERY IN PATIENTS WITH CORONARY ARTERY DISEASE

954 views • 61 slides

Results of ED Coronary CTA Trials

Results of ED Coronary CTA Trials. Udo Hoffmann, MD MPH. Disclosures. Research Grants : Bracco Diagnostics Bayer Healthcare GE Healthcare. Anderson JL et al. Circulation. 2007;116:e148-304. CT is especially suited for the ED setting.

760 views • 58 slides

Hereditary Cancer Testing Panels

Hereditary Cancer Testing Panels. Jill Siegfried, RN, MS, CGC Certified Genetic Counselor. Elizabeth Chao, MD Director of Translational Medicine. Overview. Introduction to Ambry Current Testing and Next-generation (NGS) Methodologies Overview of NGS Panels and Indications Clinical Utility

898 views • 48 slides

Hereditary Cancer Testing Panels

Hereditary Cancer Testing Panels. Jill Siegfried, RN, MS, CGC Certified Genetic Counselor. Elizabeth Chao, MD Director of Translational Medicine. Overview. Introduction to Ambry Current Testing and Next-generation (NGS) Methodologies Overview of NGS Panels and Indications Clinical Utility

667 views • 48 slides

Therapy-Related Cardiac Toxicity in Cancer Patients

Therapy-Related Cardiac Toxicity in Cancer Patients. JEAN-BERNARD DURAND, M.D., FCCP, FACC ASSOCIATE PROFESSOR OF MEDICINE MEDICAL DIRECTOR CARDIOMYOPATHY SERVICES UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER HOUSTON, TEXAS. Jean-Bernard Durand, M.D. Presenter Disclosure Information.

770 views • 47 slides

Wolfgang Koenig, MD, FESC, FACC Dept. of Internal Medicine II - Cardiology

The 2 nd Vulnerable Patient Satellite Symposium Towards a National Screening Program New Orleans, LA, March 6 th , 2004. CRP, Lp-PLA 2 , and Other Serum Markers of Disease and Vulnerability. Wolfgang Koenig, MD, FESC, FACC Dept. of Internal Medicine II - Cardiology

518 views • 39 slides

VTE and Pregnancy

VTE and Pregnancy. Huma Khan MD MCH fellow August 3 rd , 2011. objectives. Epidemiology of VTE in pregnancy to be able to identify the causes of vte To understand and identify the different diagnostic tools Understand prenatal management To be aware of the different pharmacotherapies

778 views • 38 slides

The Acute Coronary Syndromes, Including Acute MI

The Acute Coronary Syndromes, Including Acute MI. 2000 ACLS Text Consensus Guidelines. Acute Coronary Syndromes. Unstable angina Non-Q-wave MI Q-wave MI. Acute Coronary Syndromes. Are a continuum initiated by:

575 views • 36 slides

Epidemiology of Noncardiac Surgery

Epidemiology of Noncardiac Surgery. Dr. Mohammed Naser. Overview. Important Decision points: Urgent vs Elective Surgery High risk surgery vs intermediate vs low -Active Cardiac Condition vs non-active Functional capacity on basis of pt ablility To perform certain activities.

445 views • 29 slides

Practical Considerations in Chronic Ischemic Heart Disease Management

Practical Considerations in Chronic Ischemic Heart Disease Management. Angina treatment: Objectives. Reduce ischemia and relieve anginal symptoms Improve quality of life Prevent MI and death Improve quantity of life.

641 views • 28 slides

Morning Report

Morning Report. Jieli Li 11/14/05. Chief Complaint. f/c, n/v, abdominal pain. HPI. 34 y/o AAM with hx of PSA presents with f/c, n/v and abdominal pain x 5 days.

470 views • 27 slides

TREATMENT OF ACUTE CORONARY SYNDROMES

566 views • 25 slides

M R D When? How?

355 views • 21 slides

LEBANON

LEBANON. War damaged infrastructure Strained public health systems. Where in the world is Lebanon?. Physical Environment. Topography About twice the size of Delaware 4 geographic regions Coastal plain, Mountains, Agriculture, Anti-mountain Climate Varies by region

757 views • 18 slides

Methods of Tertiary prevention

522 views • 13 slides

Assessment of

Assessment of. Febrile child Ravi Seyan. F2F encounter. Consider ABC A- airways B- Breathing C- Circulation. F2F. Airway, breathing: signs of respiratory distress include recession, grunting, accessory muscle use, flared nostrils. F2F. Normal Respiration Neonates :

166 views • 8 slides

Percent of HTN subject

Distribution of global risk of cardiovascular diseas e According to Framingham and/or ESH risk scores. Low risk. Intermediate risk. High risk ( incl. CVD). Percent of HTN subject. FRS. ESH. * Combined FRS and ESH. FRS: Framingham risk score

157 views • 1 slides

OPTIMIZE-HF

OPTIMIZE-HF. Three strategies for using brain- natriuretic -peptide (BNP) levels to predict one-year outcomes. Entrance BNP. Discharge BNP. Ratio Entrance BNP : Discharge BNP. Addition of discharge BNP to risk prediction led to risk reclassification:

249 views • 1 slides